$4.08
0.09[2.26%]
At close: Apr 25
$4.08
0[0.00%]
PreMarket: 6:04PM EDT
Cardiff Oncology
(NASDAQ:CRDF)Cardiff Oncology Stock (NASDAQ:CRDF), Earnings Estimates, EPS, and Revenue
Cardiff Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS Estimate
$-0.250
Quarterly Revenue Estimate
$50K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$488K
Analyze the earnings history of Cardiff Oncology using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | PM | CRDF | Q1 | -$0.25 | -$0.25 | — | — | $83.00K | $50.00K | — | — | Get Alert |
| 02/29/2024 | PM | CRDF | Q4 | -$0.20 | -$0.28 | -$0.21 | 25.00% | $128.00K | $40.00K | $156.00K | 290.00% | Get Alert |
| 11/02/2023 | PM | CRDF | Q3 | -$0.20 | -$0.28 | -$0.22 | 21.43% | $93.00K | $60.00K | $141.00K | 135.00% | Get Alert |
| 08/09/2023 | PM | CRDF | Q2 | -$0.24 | -$0.27 | -$0.25 | 7.41% | $91.00K | $40.00K | $108.00K | 170.00% | Get Alert |
| 05/04/2023 | PM | CRDF | Q1 | -$0.25 | -$0.23 | -$0.25 | -8.70% | $74.00K | $60.00K | $83.00K | 38.33% | Get Alert |
| 03/02/2023 | PM | CRDF | Q4 | -$0.23 | -$0.23 | -$0.20 | 13.04% | $133.00K | $70.00K | $128.00K | 82.86% | Get Alert |
| 11/03/2022 | PM | CRDF | Q3 | -$0.17 | -$0.26 | -$0.20 | 23.08% | $86.00K | $70.00K | $93.00K | 32.86% | Get Alert |
| 08/04/2022 | PM | CRDF | Q2 | -$0.17 | -$0.27 | -$0.24 | 11.11% | $68.00K | $60.00K | $91.00K | 51.67% | Get Alert |
| 05/05/2022 | PM | CRDF | Q1 | -$0.14 | -$0.23 | -$0.25 | -8.70% | $72.00K | $50.00K | $74.00K | 48.00% | Get Alert |
| 02/24/2022 | PM | CRDF | Q4 | -$0.19 | -$0.17 | -$0.23 | -35.29% | $119.00K | $40.00K | $133.00K | 232.50% | Get Alert |
| 11/04/2021 | PM | CRDF | Q3 | -$0.19 | -$0.17 | -$0.17 | 0.00% | $136.00K | $30.00K | $86.00K | 186.67% | Get Alert |
| 08/05/2021 | PM | CRDF | Q2 | -$0.51 | -$0.15 | -$0.17 | -13.33% | $43.00K | $150.00K | $68.00K | -54.67% | Get Alert |
| 05/06/2021 | PM | CRDF | Q1 | -$0.41 | -$0.16 | -$0.14 | 12.50% | $68.00K | $160.00K | $72.00K | -55.00% | Get Alert |
| 02/25/2021 | PM | CRDF | Q4 | -$0.51 | — | -$0.19 | — | $93.00K | — | $119.00K | — | Get Alert |
| 11/05/2020 | PM | CRDF | Q3 | -$0.71 | — | -$0.19 | — | $52.00K | — | $136.00K | — | Get Alert |
| 08/11/2020 | PM | CRDF | Q2 | -$0.76 | — | -$0.51 | — | $138.00K | — | $43.00K | — | Get Alert |
| 05/07/2020 | PM | CRDF | Q1 | -$1.02 | — | -$0.41 | — | $162.00K | — | $68.00K | — | Get Alert |
| 02/27/2020 | PM | CRDF | Q4 | -$1.09 | -$0.65 | -$0.51 | 21.54% | $78.00K | $60.00K | $93.00K | 55.00% | Get Alert |
| 11/07/2019 | PM | CRDF | Q3 | -$0.18 | — | -$0.71 | — | $88.00K | — | $52.00K | — | Get Alert |
FAQ
When is Cardiff Oncology (NASDAQ:CRDF) reporting earnings?
Cardiff Oncology (CRDF) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
What were the latest earnings per share (EPS) for Cardiff Oncology (NASDAQ:CRDF)?
The Actual EPS was $-0.21, which beat the estimate of $-0.28.
What were Cardiff Oncology’s (NASDAQ:CRDF) revenues?
The Actual Revenue was $156K, which beat the estimate of $40K.
Browse earnings estimates, EPS, and revenue on all stocks.